[
  {
    "ts": "2025-11-04T17:38:23+00:00",
    "headline": "3 Stocks Estimated To Be Trading Below Fair Value In November 2025",
    "summary": "As the U.S. stock market experiences a pullback with major indices like the Dow Jones, Nasdaq, and S&P 500 showing declines, investors are increasingly cautious amid mixed earnings reports and fluctuating tech shares. In such an environment, identifying stocks that are trading below their fair value can offer potential opportunities for those looking to invest in assets that may be undervalued by the market.",
    "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-below-173823820.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "236687e1-6f1c-362b-99cc-6788d131f1b9",
      "content": {
        "id": "236687e1-6f1c-362b-99cc-6788d131f1b9",
        "contentType": "STORY",
        "title": "3 Stocks Estimated To Be Trading Below Fair Value In November 2025",
        "description": "",
        "summary": "As the U.S. stock market experiences a pullback with major indices like the Dow Jones, Nasdaq, and S&P 500 showing declines, investors are increasingly cautious amid mixed earnings reports and fluctuating tech shares. In such an environment, identifying stocks that are trading below their fair value can offer potential opportunities for those looking to invest in assets that may be undervalued by the market.",
        "pubDate": "2025-11-04T17:38:23Z",
        "displayTime": "2025-11-04T17:38:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/53518648b6315faea839e9bb897d943a",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4QJn9eoc5gfoPlkOk7Zoig--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/53518648b6315faea839e9bb897d943a.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q3mLJjpoAhRtzCU._fU08w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/53518648b6315faea839e9bb897d943a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-below-173823820.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-below-173823820.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PAHC"
            },
            {
              "symbol": "RMR"
            },
            {
              "symbol": "PRO"
            },
            {
              "symbol": "TOWN"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "SMWB"
            },
            {
              "symbol": "MNY"
            },
            {
              "symbol": "EGBN"
            },
            {
              "symbol": "CROX"
            },
            {
              "symbol": "COMP"
            },
            {
              "symbol": "CTRE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:45:00+00:00",
    "headline": "Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034",
    "summary": "The hyperlipidemia drugs market is growing due to rising cardiovascular disease prevalence, increasing cholesterol management awareness, and aging populations. Opportunities lie in personalized and combination therapies, digital health integration, non-statin alternatives, and expanding markets in Asia-Pacific. Hyperlipidemia Drugs Market Hyperlipidemia Drugs Market Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The \"Hyperlipidemia Drugs Market Report 2025\" has been added to ResearchAndMarkets.com's",
    "url": "https://finance.yahoo.com/news/hyperlipidemia-drugs-market-report-2025-144500707.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f41e9d02-8bb2-303f-9592-b12855a5de45",
      "content": {
        "id": "f41e9d02-8bb2-303f-9592-b12855a5de45",
        "contentType": "STORY",
        "title": "Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034",
        "description": "",
        "summary": "The hyperlipidemia drugs market is growing due to rising cardiovascular disease prevalence, increasing cholesterol management awareness, and aging populations. Opportunities lie in personalized and combination therapies, digital health integration, non-statin alternatives, and expanding markets in Asia-Pacific. Hyperlipidemia Drugs Market Hyperlipidemia Drugs Market Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The \"Hyperlipidemia Drugs Market Report 2025\" has been added to ResearchAndMarkets.com's",
        "pubDate": "2025-11-04T14:45:00Z",
        "displayTime": "2025-11-04T14:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/37f2ba6c1987ec3f95b7a9adda21e40a",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Hyperlipidemia Drugs Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d2nqQKPmXf_Z3gH4o_2k0A--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/37f2ba6c1987ec3f95b7a9adda21e40a.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wpVxz2GEI4O42YruP8xaFA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/37f2ba6c1987ec3f95b7a9adda21e40a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hyperlipidemia-drugs-market-report-2025-144500707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hyperlipidemia-drugs-market-report-2025-144500707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:11:43+00:00",
    "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
    "summary": "Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI bubble continue to mount. Tuesday’s sell-off follows a wild start to the week, during which the Dow Jones Industrial Average traded lower due ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
    "url": "https://247wallst.com/investing/2025/11/04/here-are-tuesdays-top-wall-street-analyst-research-calls-apple-abbvie-broadcom-cyberark-palantir-technologies-and-more/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0548d709-246a-3fcf-bf46-2c4a80dfb822",
      "content": {
        "id": "0548d709-246a-3fcf-bf46-2c4a80dfb822",
        "contentType": "STORY",
        "title": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
        "description": "",
        "summary": "Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI bubble continue to mount. Tuesday’s sell-off follows a wild start to the week, during which the Dow Jones Industrial Average traded lower due ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
        "pubDate": "2025-11-04T14:11:43Z",
        "displayTime": "2025-11-04T14:11:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8oHqLvL4LSIh_k84TF28VQ--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M2B5MfoEY0V7wX_NrqStUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/11/04/here-are-tuesdays-top-wall-street-analyst-research-calls-apple-abbvie-broadcom-cyberark-palantir-technologies-and-more/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tuesday-top-wall-street-analyst-141143807.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "DKNG"
            },
            {
              "symbol": "TWST"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "RRR"
            },
            {
              "symbol": "CI"
            },
            {
              "symbol": "CIVI"
            },
            {
              "symbol": "CIVII"
            },
            {
              "symbol": "CZR"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "CMCSA"
            },
            {
              "symbol": "WM"
            },
            {
              "symbol": "SM"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "ETH-USD"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "CYBR"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T11:38:02+00:00",
    "headline": "3 Stocks Estimated To Be Trading Up To 25.8% Below Intrinsic Value",
    "summary": "As the U.S. stock market navigates a mixed landscape, with the Nasdaq gaining momentum from tech deals and the Dow facing headwinds, investors are keenly focused on earnings reports and employment data amid a prolonged government shutdown. In this environment, identifying undervalued stocks becomes crucial for those looking to capitalize on potential opportunities; these stocks are estimated to be trading significantly below their intrinsic value, offering possible long-term benefits amidst...",
    "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-25-113802073.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ab5e5390-3a1a-33af-9d85-e8957c2e9c27",
      "content": {
        "id": "ab5e5390-3a1a-33af-9d85-e8957c2e9c27",
        "contentType": "STORY",
        "title": "3 Stocks Estimated To Be Trading Up To 25.8% Below Intrinsic Value",
        "description": "",
        "summary": "As the U.S. stock market navigates a mixed landscape, with the Nasdaq gaining momentum from tech deals and the Dow facing headwinds, investors are keenly focused on earnings reports and employment data amid a prolonged government shutdown. In this environment, identifying undervalued stocks becomes crucial for those looking to capitalize on potential opportunities; these stocks are estimated to be trading significantly below their intrinsic value, offering possible long-term benefits amidst...",
        "pubDate": "2025-11-04T11:38:02Z",
        "displayTime": "2025-11-04T11:38:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b7c341d09b501267c28edded63e372d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YoHdk.1NHzt1lhVH3ESzAg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7c341d09b501267c28edded63e372d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DBlcNdfCvxdawLqCS5gqxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b7c341d09b501267c28edded63e372d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-25-113802073.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-25-113802073.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "PDFS"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "CCB"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "TOWN"
            },
            {
              "symbol": "SMWB"
            },
            {
              "symbol": "ONB"
            },
            {
              "symbol": "MNY"
            },
            {
              "symbol": "EGBN"
            },
            {
              "symbol": "CROX"
            },
            {
              "symbol": "COMP"
            },
            {
              "symbol": "CTRE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T10:15:00+00:00",
    "headline": "2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon",
    "summary": "Healthcare has been an extraordinarily resilient industry to put cash to work in through the years.",
    "url": "https://www.fool.com/investing/2025/11/04/2-healthcare-stocks-for-individual-investors-with/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f0e2b1b4-cb28-360d-b50d-1b9fbe58b181",
      "content": {
        "id": "f0e2b1b4-cb28-360d-b50d-1b9fbe58b181",
        "contentType": "STORY",
        "title": "2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon",
        "description": "",
        "summary": "Healthcare has been an extraordinarily resilient industry to put cash to work in through the years.",
        "pubDate": "2025-11-04T10:15:00Z",
        "displayTime": "2025-11-04T10:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/d076139a61172941f179fac1f6d61c63",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Person reviewing stock charts on computer screens.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0W03VJM6IeQyGkwj2W2a1A--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/d076139a61172941f179fac1f6d61c63.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DSim6TBeGaR1lAm972Sm9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/d076139a61172941f179fac1f6d61c63.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/04/2-healthcare-stocks-for-individual-investors-with/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-healthcare-stocks-individual-investors-101500458.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T08:01:00+00:00",
    "headline": "BioSpace Announces 2026 Best Places to Work in Life Sciences Winners",
    "summary": "BioSpace, the leader in biopharma news and careers, has published its 2026 Best Places to Work list.",
    "url": "https://finance.yahoo.com/news/biospace-announces-2026-best-places-080100604.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "1d6ed555-a775-3a47-97c7-67dfcf7a34c6",
      "content": {
        "id": "1d6ed555-a775-3a47-97c7-67dfcf7a34c6",
        "contentType": "STORY",
        "title": "BioSpace Announces 2026 Best Places to Work in Life Sciences Winners",
        "description": "",
        "summary": "BioSpace, the leader in biopharma news and careers, has published its 2026 Best Places to Work list.",
        "pubDate": "2025-11-04T08:01:00Z",
        "displayTime": "2025-11-04T08:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/e926a1897d0bf3a2c3e7f8f57662d00f",
          "originalWidth": 400,
          "originalHeight": 382,
          "caption": "BioSpace’s annual Best Places to Work list showcases top biotech and pharma employers.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DiR7o2txiVyjsfD4hLq0Yg--~B/aD0zODI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/e926a1897d0bf3a2c3e7f8f57662d00f.cf.webp",
              "width": 400,
              "height": 382,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t3cpINqd6.r93_4w8UzXHQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/e926a1897d0bf3a2c3e7f8f57662d00f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biospace-announces-2026-best-places-080100604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biospace-announces-2026-best-places-080100604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]